Get started
Author

Qingwen Xu

Prognostic Significance of Preoperative Lymphocyte-to-C-Reactive Protein Ratio in Patients with Non-Metastatic Colorectal Cancer
2021 · Wenting Ou, Caijin Zhou, et al. · OncoTargets and Therapy · 18
PDF
Problems and challenges encountered by Chinese medical institutions in implementing the national centralized drug procurement
2023 · Wen Zhang, Qingwen Xu, et al. · Frontiers in Pharmacology · 15
Chemoprotective effect of boeravinone B against 1,2-dimethyl hydrazine induced colorectal cancer in rats via suppression of oxidative stress and inflammatory reaction
2022 · Caijin Zhou, Wenting Ou, et al. · Journal of Gastrointestinal Oncology · 13
PDF
Risk prediction models for difficult cholecystectomy.
2022 · Gan Chen, Min Li, et al. · Videosurgery and Other Miniinvasive Techniques · 11
PDF
Digital financial inclusion as a safety net: Empowering households against health shocks
2025 · Qingwen Xu, Chun Liu, et al. · Economic Modelling · 10
siTGF-β1 and pirfenidone contained Ionizable-Liposomal nanodrug for enhanced treatment of Idiopathic pulmonary fibrosis
2024 · Chenggong Yu, Qingwen Xu, et al. · Chemical Engineering Journal · 10
FLASH radiotherapy: mechanisms, nanotherapeutic strategy and future development
2024 · Yan Wang, Huifang Wang, et al. · Nanoscale Advances · 6
PDF
Anoctamin 1 Inhibition Suppresses Cystogenesis by Enhancing Ciliogenesis and the Ciliary Dosage of Polycystins
2022 · Tao Xu, Meihan Chen, et al. · Frontiers in Bioscience-Landmark · 6
PDF
Thermal aged XLPE cables restoration by injecting hydrolyzable voltage stabilizer
2022 · Mingyue Li, Yidong Chen, et al. · Journal of Polymer Research · 5
[Retracted] Systematic Review and Meta‐Analysis Program Based on Effectiveness of a Multidisciplinary Model of Care for Patients with Chronic Kidney Disease
2022 · Qinger Wang, Mengyuan Ge, et al. · Contrast Media & Molecular Imaging · 3
PDF
Health Shocks and Consumption Smoothing: The Role of Digital Financial Inclusion
2024 · Chun Liu, Qingwen Xu, et al. · SSRN Electronic Journal · 2
The Risk of Timing Out: Welfare-to-Work Services to Asian Immigrants and Refugees
2005 · Julian Chow, Kathy Osterling, et al. · 2
Correction to “Copolymer Brushes with Temperature-Triggered, Reversibly Switchable Bactericidal and Antifouling Properties for Biomaterial Surfaces”
2022 · Bailiang Wang, Qingwen Xu, et al. · ACS Applied Materials & Interfaces · 1
Consistency analysis of DFIG wind generation models in PSS/E and PSASP
2015 · Tao Fu, Hengxu Zhang, et al. · IEEE International Conference on Electric Utility Deregulation, Restructuring and Power Technologies · 1
Correction: Identification and experimental validation of ulcerative colitis-associated hub genes through integrated WGCNA and lysosomal autophagy analysis
2025 · Yuanpei Zhao, Yijun Li, et al. · Human Genomics
PDF
Data from Combined Inhibition of NEDD8-Activating Enzyme and mTOR Suppresses NF2 Loss–Driven Tumorigenesis
2023 · Jonathan Cooper, Qingwen Xu, et al.
Data from Combined Inhibition of NEDD8-Activating Enzyme and mTOR Suppresses NF2 Loss–Driven Tumorigenesis
2023 · Jonathan Cooper, Qingwen Xu, et al.
Figure S3 from Combined Inhibition of NEDD8-Activating Enzyme and mTOR Suppresses NF2 Loss–Driven Tumorigenesis
2023 · Jonathan Cooper, Qingwen Xu, et al.
Figure S1 from Combined Inhibition of NEDD8-Activating Enzyme and mTOR Suppresses NF2 Loss–Driven Tumorigenesis
2023 · Jonathan Cooper, Qingwen Xu, et al.
Figure S4 from Combined Inhibition of NEDD8-Activating Enzyme and mTOR Suppresses NF2 Loss–Driven Tumorigenesis
2023 · Jonathan Cooper, Qingwen Xu, et al.
Figure S2 from Combined Inhibition of NEDD8-Activating Enzyme and mTOR Suppresses NF2 Loss–Driven Tumorigenesis
2023 · Jonathan Cooper, Qingwen Xu, et al.
Supplementary Text from Combined Inhibition of NEDD8-Activating Enzyme and mTOR Suppresses NF2 Loss–Driven Tumorigenesis
2023 · Jonathan Cooper, Qingwen Xu, et al.
Figure S1 from Combined Inhibition of NEDD8-Activating Enzyme and mTOR Suppresses NF2 Loss–Driven Tumorigenesis
2023 · Jonathan Cooper, Qingwen Xu, et al.
Figure S3 from Combined Inhibition of NEDD8-Activating Enzyme and mTOR Suppresses NF2 Loss–Driven Tumorigenesis
2023 · Jonathan Cooper, Qingwen Xu, et al.
Figure S4 from Combined Inhibition of NEDD8-Activating Enzyme and mTOR Suppresses NF2 Loss–Driven Tumorigenesis
2023 · Jonathan Cooper, Qingwen Xu, et al.
Works count: 37
Citation count: 103
H-index: 6
I10-index: 6
Year
Topic
Type